EXOT Platform
MISSION
"To create a world where all innovative ideas that contribute to the advancement of human health can be realized, free from the barriers of capital."
What is the EXOT Platform?
A Hybrid DeSci-RWA Framework: The Next-Generation Business Model for Decentralized Biotech Investment
The EXOT platform is a vast financial ecosystem where investors, biotech companies, and expert groups interact organically. It is a decentralized platform that democratically provides innovative investment opportunities, particularly in the field of exosome biotechnology, to investors worldwide.
✔ Core Values of the EXOT Platform
The world’s first integrated investment system combining DeSci × RWA × ESG
A fully on-chain ecosystem where biotech companies, investors, and experts collaborate
AI-powered due diligence, DAO-driven decision-making, and RWA-backed value stability
An open structure that anyone can participate in, while ensuring both expertise and transparency
How the EXOT Platform Works
The EXOT platform operates through a sophisticated five-stage investment process built on transparent blockchain technology and a professional verification framework. Each stage is systematically designed to maximize the reliability of biotech projects and the efficiency of investment, forming a next-generation on-chain ecosystem powered by AI-driven analysis and DAO-based governance.
Step
Key Features
Core Roles(Outcomes)
Base. Get EXOT
• Purchase EXOT (CEX/DEX Hybrid) • KYC / Payment / Bridge Support • Trading pairs (EXOT–USDT, EXOT–GOLDPAY, etc.) • Onboarding interface for new users
Acquire EXOT needed for DAO governance and staking participation
1. Deal Sourcing
• Project submission by biotech startups/researchers • Upload technical documents, IR materials, research data • Basic verification (initial screening)
Projects converted into candidates for full due diligence
2. In-Depth Due Diligence
• Technical & data validation • Deep review by SAB (expert panel) • AI-driven analysis by EXOT Agents
SAB evaluation report + AI analysis report created for DAO voting
3. DAO Decision-Making
• EXOT token holders vote • Gasless voting via Snapshot • Decisions based on due diligence reports
EXOT (Strategic Investor), On-chain Record System
4. Investment Execution & Staking
• Users stake EXOT into approved projects • Display projected yields & reward structures • On-chain reward distribution
• Final approval of investment-worthy projects • DAO Treasury investment authorization
5. Post-Investment Growth Support
• EXOT acts as a Strategic Investor • Support tech development, clinical progress, partnerships • On-chain milestone tracking & performance-based incentives
• Increased project success rate • Growth of ecosystem value (NAV)
[Base Layer] Get EXOT: Token Acquisition & Liquidity Entry
The Get EXOT Platform serves as the foundational infrastructure (Base Layer) that supports the entire EXOT ecosystem. All users obtain EXOT tokens through this platform, enabling participation in the DAO, staking, and every other stage that requires token involvement. Every stage of the EXOT ecosystem operates on top of this foundational layer.
Key Features
Purchase EXOT tokens (CEX/DEX Hybrid UI)
KYC / payment system / bridging support
Trading pairs such as EXOT–USDT, EXOT–GOLDPAY, and more
User-friendly onboarding interface designed for new entrants
Core Roles
Secure EXOT tokens for DAO governance participation
Prepare tokens for staking participation
Establish a foundation for liquidity provision
Act as the primary entry point for new users entering the ecosystem
Key Participants : New users, general token purchasers, DAO participants, staking participants
[Stage 1] Project Discovery & Registration: Deal Sourcing
Biotech project submission (by biotech companies or researchers) → Upload of technical documents, IR materials, and research results → Basic verification (initial screening)
Key Features
Biotech startups and research teams submit and register their projects
Upload technical documents, research outcomes, and IR materials
Basic verification (Initial Screening):
Required document check
Preliminary data validation
Technology fit assessment
Automated data collection and project metadata generation
Outcome Projects that pass the basic screening are advanced to the official in-depth due diligence phase.
Platform Type : Web dApp + Admin CMS (Onboarding Platform) Key Participants : Biotech companies, researchers, EXOT operations team
[Stage 2] Expert In-Depth Due Diligence
Projects that pass the initial screening undergo technical and documentation verification, followed by a comprehensive due diligence process conducted by the SAB (Scientific Advisory Board), a group of top-tier experts.
Key Features ✔ Technical & Documentation Verification
Validate the baseline quality of research data
Identify fundamental technical risk factors
Assess the credibility and consistency of submitted documents
✔ In-Depth Due Diligence by the Scientific Advisory Board (SAB)
Evaluate technical feasibility and clinical potential
Analyze patents/IP, market potential, and competitive landscape
Assess commercialization viability
✔Automated Analysis by EXOT Agents (AI)
Automated literature analysis based on research papers and datasets
Predictive modeling for clinical feasibility
Automated data validation and hypothesis testing
Outcome A combined SAB Due Diligence Report + AI Analysis Report is generated and used as the official reference document for DAO governance voting.
Key Participants : SAB (Scientific Advisory Board), EXOT Operations Team
[Stage 3] DAO Decision-Making
Final investment decisions are made through an on-chain governance voting process.
Key Features
EXOT token holders participate in governance voting
Project-specific approval/disapproval voting and comment submission
Gasless voting powered by Snapshot
Decision-making based on the official due diligence reports
Outcome
Projects approved by the DAO are registered as official investment and staking targets
DAO Treasury determines capital allocation and support for the selected projects
Platform Type : Web3 Governance dApp (EXOT DAO) Key Participants : Token holders, DAO participants
[Stage 4] Investment Execution & Staking
Through institutional investment, EXOT is secured, and users participate in project-specific EXOT staking, enabling full project funding.
Key Features
Users stake EXOT into approved projects
Displays project-specific expected returns and reward structures
DAO sets staking periods and allocation limits for each project
Rewards are distributed through on-chain transactions
Outcome User staking participation completes project funding and provides the capital necessary for project growth.
Platform Type : DApp - Wallet Connection / On-chain Transactions (EXOT Staking) Key Participants : General users and institutional investors
[Stage 5] Post-Investment Growth Support & On-Chain Monitoring
Key Features
EXOT acts as a Strategic Investor (SI), directly supporting the growth of the invested company
Provides practical support including technology development, clinical progress assistance, and partnership building
Tracks milestone achievement through a dedicated on-chain record system
Automatically adjusts performance-based incentives (rewards) according to real progress
DAO community can participate in follow-up support when necessary
Outcome
Increased likelihood of project success
Overall ecosystem value (NAV) growth
Expanded potential for investors to realize tangible returns
Key Participants : EXOT operations team and DAO participants
Core Growth Engine
An In-Depth Analysis of the Impact-Alpha Flywheel
The core engine driving the sustainable growth of the EXOT platform is the 'Impact-Alpha Flywheel' model. Here, 'Impact' refers to the social value of contributing to human health, while 'Alpha' signifies the financial returns that exceed the market average. The essence of the flywheel is a virtuous cycle where these two elements mutually reinforce each other.
Phase
Direction
Mechanism
Outcome
Acceleration 1
Impact Alpha
Successful investment/commercialization of treatments for intractable diseases (Impact)
Generates High Financial Returns (Alpha), enhances platform reputation
Acceleration 2
Alpha Impact
Reinvestment of generated returns (Alpha) into the DAO treasury
Contributes to the development of more promising technologies/rare disease treatments (Impact)
Virtuous Cycle
Mutually Reinforcing
Impact and Alpha accelerate each other, ensuring sustainable growth
Strengthened social influence and brand value Expanded investment resources
Investment Strategy and Portfolio Composition
As the first proof-of-concept for the EXOT platform, we have selected the 'exosome' market, which holds the most explosive growth potential among all current biotechnologies. Exosomes are a 'game-changer' in regenerative medicine, drug delivery systems (DDS), and next-generation diagnostics, with an average annual growth rate exceeding 30%. By concentrating our investments in exosome technology companies selected through a stringent evaluation process, we will validate the platform's potential for success and deliver high capital gains to our early investors.
The EXOT platform adopts a Smart Beta strategy to systematically manage the high risks associated with biotech investing. The portfolio is diversified by development stage, therapeutic area, and geographical region. Each investment is selected only after rigorous scientific validation and commercial feasibility assessment.
The EXOT platform focuses on the following investment stages and allocations
Investment Area
Weight
Characteristic
Exosome Therapeutics
40%
EXOT's core specialization (Next-generation therapeutic platforms)
Rare Disease Treatments
25%
Potential for high pricing
Immuno-Oncology
20%
Innovative fields like CAR-T, checkpoint inhibitors
Neurodegenerative Diseases
10%
Unmet medical needs like Alzheimer's
Other Innovation
5%
Next-generation biotech like gene editing, synthetic biology
By establishing these clear, high-growth core investment areas, the EXOT platform will build stable initial value for the protocol and demonstrate the success potential of the 'Impact-Alpha Flywheel' model.
EXOT Platform's Differentiated Advantages
Perfect Market Timing: Launching in a market that is 3.8 times more mature compared to the inception of VitaDAO.
Unmatched Expertise: Possessing a world-class Scientific Advisory Board in the field of exosomes.
Technical Maturity: Built with MiCA-compliant and institutional-grade infrastructure.
Portfolio Diversity: Employing a global, diversified investment strategy not limited to a single region or technology.
Vision and Expected Impact
The EXOT platform aims to do more than just create a new investment product; it seeks to shift the paradigm of the entire biotech investment ecosystem.
Target
Vision & Expected Benefit
Detail
To Investors
Access to institutional-grade deals & High liquidity
Small-scale participation in promising deals, flexible capital recovery
To Bio Company
New funding channel to overcome the 'Valley of Death'
Securing financing and receiving support from the global community
To Humanity
Accelerated development of innovative treatments
Contributing to human health, increased access to life-saving discoveries
Overall Vision
EXOT will be the most trusted financial infrastructure for next-generation biotech.
By breaking down existing barriers in biotechnology and introducing a permissionless framework, EXOT can accelerate life-saving discoveries while making them more accessible to everyone. We are confident that this will establish EXOT as the most trusted financial infrastructure for the next generation of biotechnology.
Last updated